Skip to main content
logo
Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
1.900
+0.040 (2.15%)
At close: Sep 18, 2026, 4:00 PM EDT
1.919
+0.019 (1.02%)
After-hours: Sep 18, 2026, 7:59 PM EDT

Tenax Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1094952187526
Market Cap Growth
-56.45%126.39%3233.86%31.60%-81.01%11.69%
Enterprise Value
-9395120-4118
Last Close Price
1.9012.196.1921.97178.241664.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.875.102.380.813.346.18
P/TBV Ratio
0.965.102.380.813.346.18

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---0.060.540.07
Net Debt / Equity Ratio
-1.04-1.00-1.03-1.15-0.88-1.25
Net Debt / EBITDA Ratio
--4.871.130.120.17
Net Debt / FCF Ratio
2.562.736.401.570.120.49
Quick Ratio
14.6113.6320.212.731.153.57
Current Ratio
15.0714.5720.603.261.743.64
Return on Equity (ROE)
-59.80%-55.64%-35.17%-160.80%-385.12%-732.21%
Return on Assets (ROA)
-37.70%-35.08%-22.48%-68.21%-147.02%-306.43%
Return on Capital Employed (ROCE)
-60.40%-58.10%-21.20%-101.70%-709.90%-712.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-59.60%-10.64%-8.06%-117.68%-221.89%-123.88%
FCF Yield
-42.29%-7.24%-6.78%-90.10%-228.78%-41.43%
Buyback Yield / Dilution
-31.87%-156.80%-6046.87%-1250.92%-43.00%-
SEC Filings: 10-K · 10-Q